Insiders sold $7.87M and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Executive Vice Pres & COO Ram R. Krishnan sold $1.62M on Jun 1, 5.1% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2023.
Get an email when EMR's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Aug 11 | Surendralal Lanca Karsanbhai President & CEO | SoldNo plan | 9,650 | $161.91 | $1.56M | 2.1% | Form 4 |
| Aug 6 | Michael H. Train SVP & Chief Sustain Officer | SoldNo plan | 7,329 | $158.99 | $1.17M | 2.8% | Form 4 |
| Jun 1 | Ram R. Krishnan Executive Vice Pres & COO | SoldNo plan | 11,500 | $141.22 | $1.62M | 5.1% | Form 4 |
| Mar 10 | Surendralal Lanca Karsanbhai President & CEO | SoldNo plan | 5,700 | $142.32 | 811K | 1.2% | Form 4 |
| Feb 10 | Matthew S Levatich Director | SoldNo plan | 1,476 | $162.16 | 239K | 5.7% | Form 4 |
| Feb 9 | Nicholas J. Piazza Senior VP & CPO | SoldNo plan | 6,703 | $159.07 | $1.07M | 17% | Form 4 |
| Feb 5 | Mark A Blinn Director | SoldNo plan 2 parts | 2,876 | $152.62 average | 439K | 28% | Form 4 |
| Dec 3, 2025 | Surendralal Lanca Karsanbhai President & CEO | SoldNo plan | 7,263 | $133.00 | 966K | 1.5% | Form 4 |
| May 12, 2025 | Michael H. Train SVP & Chief Sustain Officer | SoldNo plan | 28,305 | $119.44 | $3.38M | 10% | Form 4 |
| May 8, 2025 | Surendralal Lanca Karsanbhai President & CEO | SoldNo plan | 16,698 | $113.33 | $1.89M | 4.5% | Form 4 |
| Feb 12, 2025 | Mark A Blinn Director | SoldNo plan | 20 | $125.24 | 3K | 0.2% | Form 4 |
| Feb 12, 2025 | Matthew S Levatich Director | SoldNo plan | 1,867 | $125.05 | 233K | 7.1% | Form 4 |
| Feb 10, 2025 | Mark A Blinn Director | SoldNo plan | 1,867 | $125.71 | 235K | 17% | Form 4 |
| Nov 13, 2024 | Surendralal Lanca Karsanbhai CEO and President | SoldNo plan | 52,409 | $130.51 | $6.84M | 12% | Form 4 |
| Nov 6, 2024 | Michael H. Train SVP & Chief Sustain Officer | SoldNo plan | 21,525 | $125.96 | $2.71M | 7.3% | Form 4 |
- Aug 11No planSurendralal Lanca KarsanbhaiPresident & CEO · sold 9,650 at $161.91$1.56M2.1% of stake
- Aug 6No planMichael H. TrainSVP & Chief Sustain Officer · sold 7,329 at $158.99$1.17M2.8% of stake
- Jun 1No planRam R. KrishnanExecutive Vice Pres & COO · sold 11,500 at $141.22$1.62M5.1% of stake
- Mar 10No planSurendralal Lanca KarsanbhaiPresident & CEO · sold 5,700 at $142.32811K1.2% of stake
- Feb 10No planMatthew S LevatichDirector · sold 1,476 at $162.16239K5.7% of stake
- Feb 9No planNicholas J. PiazzaSenior VP & CPO · sold 6,703 at $159.07$1.07M17% of stake
- Feb 5No planMark A BlinnDirector · sold 2,876 at avg $152.62439K28% of stake
- Dec 3, 2025No planSurendralal Lanca KarsanbhaiPresident & CEO · sold 7,263 at $133.00966K1.5% of stake
- May 12, 2025No planMichael H. TrainSVP & Chief Sustain Officer · sold 28,305 at $119.44$3.38M10% of stake
- May 8, 2025No planSurendralal Lanca KarsanbhaiPresident & CEO · sold 16,698 at $113.33$1.89M4.5% of stake
- Feb 12, 2025No planMark A BlinnDirector · sold 20 at $125.243K0.2% of stake
- Feb 12, 2025No planMatthew S LevatichDirector · sold 1,867 at $125.05233K7.1% of stake
- Feb 10, 2025No planMark A BlinnDirector · sold 1,867 at $125.71235K17% of stake
- Nov 13, 2024No planSurendralal Lanca KarsanbhaiCEO and President · sold 52,409 at $130.51$6.84M12% of stake
- Nov 6, 2024No planMichael H. TrainSVP & Chief Sustain Officer · sold 21,525 at $125.96$2.71M7.3% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Electronic & Other Electrical Equipment (No Computer Equip) · Pick stocks to compare with EMR
Held by ETFs
EMR is in 284 US ETFs. The largest of them, with EMR's weight in each:
Spot a number that looks wrong? Check it in EMR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing EMR
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.